investors.audentestx.com investors.audentestx.com

investors.audentestx.com

Overview - Audentes Therapeutics

Audentes Therapeutics Inc at 35th Annula J.P Morgan Healthcare Conference. 160;at 5:00 pm PT. Audentes Therapeutics Inc at 35th Annula J.P Morgan Healthcare Conference. Tuesday, January 10, 2017 . 5:00 pm PT  . Click here for webcast. Click here to add this event to your calendar. Data as of 01/11/17 4:00 pm ET. Audentes Therapeutics Provides Full Year 2017 Strategic Outlook and Financial Guidance. Audentes Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference.

http://investors.audentestx.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTORS.AUDENTESTX.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

February

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Monday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.5 out of 5 with 8 reviews
5 star
4
4 star
0
3 star
2
2 star
0
1 star
2

Hey there! Start your review of investors.audentestx.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

1.1 seconds

CONTACTS AT INVESTORS.AUDENTESTX.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Overview - Audentes Therapeutics | investors.audentestx.com Reviews
<META>
DESCRIPTION
Audentes Therapeutics Inc at 35th Annula J.P Morgan Healthcare Conference. 160;at 5:00 pm PT. Audentes Therapeutics Inc at 35th Annula J.P Morgan Healthcare Conference. Tuesday, January 10, 2017 . 5:00 pm PT  . Click here for webcast. Click here to add this event to your calendar. Data as of 01/11/17 4:00 pm ET. Audentes Therapeutics Provides Full Year 2017 Strategic Outlook and Financial Guidance. Audentes Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference.
<META>
KEYWORDS
1 audentes therapeutics
2 technology
3 pipeline
4 collaboration
5 advocacy
6 investors and news
7 careers
8 investors
9 overview
10 webcast
CONTENT
Page content here
KEYWORDS ON
PAGE
audentes therapeutics,technology,pipeline,collaboration,advocacy,investors and news,careers,investors,overview,webcast,webcast presentation,add to calendar,stock information,bold common stock,exchange,nasdaq,us dollar,price,change,volume,refresh quote
POWERED BY
ASP.NET
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Overview - Audentes Therapeutics | investors.audentestx.com Reviews

https://investors.audentestx.com

Audentes Therapeutics Inc at 35th Annula J.P Morgan Healthcare Conference. 160;at 5:00 pm PT. Audentes Therapeutics Inc at 35th Annula J.P Morgan Healthcare Conference. Tuesday, January 10, 2017 . 5:00 pm PT  . Click here for webcast. Click here to add this event to your calendar. Data as of 01/11/17 4:00 pm ET. Audentes Therapeutics Provides Full Year 2017 Strategic Outlook and Financial Guidance. Audentes Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference.

INTERNAL PAGES

investors.audentestx.com investors.audentestx.com
1

Process Calendar

http://investors.audentestx.com/ProcessCalendarRequest.asp?eventId=5245264&OverridePage=irol-EventDetails&checkJS=false

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

1

LINKS TO THIS WEBSITE

audentestx.com audentestx.com

Rare Disease Gene Therapy Biotechnology Company

http://audentestx.com/content/company/index.htm

Investors & News. Audentes Therapeutics is a biotechnology company committed to the development and commercialization of innovative new gene therapy treatments for people with serious rare diseases. We are a focused, experienced and passionate team driven by the goal of improving the lives of patients. We currently have four programs in development:. For the treatment of. Board of Scientific and Clinical Advisors.

audentestx.com audentestx.com

Audentes Therapeutics Announces New Data To Be Presented At American Society Of Gene And Cell Therapy Annual Meeting - Audentes Therapeutics

http://audentestx.com/content/news/releases/051115.htm

Investors & News. Audentes Therapeutics Announces New Data To Be Presented At American Society Of Gene And Cell Therapy Annual Meeting. Compelling additional preclinical data further support therapeutic potential of gene therapy products to treat X-Linked Myotubular Myopathy and Pompe Disease. AT001 (AAV-MTM1) for XLMTM. AT002 (AAV-GAA) for Pompe Disease. The abstracts are listed below. Mack, et. al., Minimally Effective Dose of Systemic AAV8-MTM1 Needed to Prolong Survival and Correct Severe Mus...Dr Bu...

audentestx.com audentestx.com

Gene Therapy for the Treatment of Rare Diseases

http://audentestx.com/content/pipeline/index.htm

Investors & News. Audentes Therapeutics is a biotechnology company committed to the development and commercialization of innovative new gene therapy treatments for people with serious rare diseases through the application of adeno-associated virus gene therapy technology. We have four programs in our pipeline:. AT132 for the treatment of X-Linked Myotubular Myopathy (XLMTM). For more information about XLMTM, please go here. AT342 for the treatment of Crigler-Najjar Syndrome (CN).

audentestx.com audentestx.com

Audentes Therapeutics To Participate In 2015 Piper Jaffray Genomerx Symposium & 1x1 Day - Audentes Therapeutics

http://audentestx.com/content/news/releases/051415.htm

Investors & News. Audentes Therapeutics To Participate In 2015 Piper Jaffray Genomerx Symposium and 1×1 Day. About Audentes Therapeutics, Inc. For more information regarding Audentes, please visit www.audentestx.com. About X-Linked Myotubular Myopathy (XLMTM). AT001 is a novel product based on AAV gene therapy technology. Please provide us with your e-mail address to keep you. Updated on all of our latest news:.

audentestx.com audentestx.com

Patient Advocacy at Audentes

http://audentestx.com/content/patients/index.htm

Investors & News. The role of Patient Advocacy at Audentes is to bring the voices of the patient community to Audentes and the voice of Audentes to the patient community. Our commitment to patient advocacy is one of our core corporate values. The individuals and families affected by the rare and devastating diseases we serve are our partners, collaborators and teachers. We welcome any feedback you may have. Please contact us directly at patientadvocacy@audentestx.com. Symptoms of Pompe Disease.

audentestx.com audentestx.com

News - Audentes Therapeutics

http://audentestx.com/content/news/index.htm

Investors & News. May 4, 2016. Audentes Therapeutics and the University of Pennsylvania Announce Collaboration to Develop AAV Gene Therapy for Severe Liver Disease. Apr 27, 2016. Audentes Therapeutics Announces Presentation of Data at the American Society of Gene and Cell Therapy Annual Meeting. Jan 5, 2016. Audentes Therapeutics Appoints Scott W. Morrison to Board of Directors. Oct 13, 2015. Audentes Therapeutics Raises $65 Million In Series C Financing. Sep 29, 2015. Sep 1, 2015. Aug 26, 2015.

audentestx.com audentestx.com

Strong Global Relationships with Rare Disease Communities

http://audentestx.com/content/collaboration/index.htm

Investors & News. Audentes takes pride in strong, global relationships with the patient, research and medical communities. We invite you to contact us. To learn more about our company, potential partnerships and our commitment to patients. Audentes is pleased to collaborate with the following organizations as we advance our programs:.

audentestx.com audentestx.com

News - Audentes Therapeutics

http://audentestx.com/content/news/releases/042115.htm

Investors & News. May 4, 2016. Audentes Therapeutics and the University of Pennsylvania Announce Collaboration to Develop AAV Gene Therapy for Severe Liver Disease. Apr 27, 2016. Audentes Therapeutics Announces Presentation of Data at the American Society of Gene and Cell Therapy Annual Meeting. Jan 5, 2016. Audentes Therapeutics Appoints Scott W. Morrison to Board of Directors. Oct 13, 2015. Audentes Therapeutics Raises $65 Million In Series C Financing. Sep 29, 2015. Sep 1, 2015. Aug 26, 2015.

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL LINKS TO THIS WEBSITE

10

SOCIAL ENGAGEMENT



OTHER SITES

investors.atento.com investors.atento.com

Atento - Investor Relations - Company Overview

Atento: Great Place To Work. Join the Atento team. Stock Quote, Historical, Chart, Calculator. Atento in the World. USA and Puerto Rico. Together we can do anything. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Stock Quote, Historical, Chart, Calculator. 98 delivery centers in 14 countries. 160,000 employees and 89,000 workstations. Long-standing relationships with 400 blue-chip clients. Strong relationship with Telefónica, supported by a Master Services Agreement ( MSA ) through 2021. We hav...

investors.atlanticpower.com investors.atlanticpower.com

Corporate Profile | Atlantic Power Corporation

Email Notification for TSX. Email Notification for NYSE. Supplementary Investor Materials - September 16, 2014. 2015 Annual General and Special Meeting. Atlantic Power Corporation Second Quarter 2015 Conference Call. Tuesday, August 11, 2015, 8:30 am ET. Atlantic Power Corporation ATP Conference Call. Friday, May 8, 2015, 8:30 am ET. Atlantic Power Corporation Fourth Quarter 2014 Conference Call. Friday, February 27, 2015, 8:30 am ET. Atlantic Power Corporation Third Quarter 2014 Conference Call. Atlanti...

investors.atlanticus.com investors.atlanticus.com

Atlanticus - For Investors - Corporate Profile

Annual Meeting of Shareholders. News and Market Information. Forward-Looking Information and Risk Factors. Â Â Corporate Information. Â Â Corporate ProfileÂ. Invests in businesses primarily focused in the financial services industry. The company exists to create value â for our customers, our employees and our shareholders. List of all companies in The SNL U.S. Finance Company Index. As of August 14, 2015. Minimum 20 minute delay. Atlanta, GA 30328. 770) 828-2000 investors@atlanticus.com. Â Â Terms of Use.

investors.atlassian.com investors.atlassian.com

Atlassian - Investors Overview

Project and issue tracking. IT and business service desk. Team chat, video, file sharing. Plan, build, and ship amazing products. Provide great service and support your business. Bring together a winning go-to-market strategy. Simplify what it takes to report, measure, and analyze. Run your business smoothly and efficiently. Streamline processes for better people management. Securely and reliably manage clients and documents. Work smart and deliver fast with any team. Guides to all our products. Atlassia...

investors.atlasventure.com investors.atlasventure.com

Login

If you have forgotten your Username or Password, please click here. For assistance logging into WebLP, please email Atlas Venture LP Relations at: lprelations@atlasventure.com. 2000-10 AnalytX, Inc.

investors.audentestx.com investors.audentestx.com

Overview - Audentes Therapeutics

Audentes Therapeutics Inc at 35th Annula J.P Morgan Healthcare Conference. 160;at 5:00 pm PT. Audentes Therapeutics Inc at 35th Annula J.P Morgan Healthcare Conference. Tuesday, January 10, 2017 . 5:00 pm PT  . Click here for webcast. Click here to add this event to your calendar. Data as of 01/11/17 4:00 pm ET. Audentes Therapeutics Provides Full Year 2017 Strategic Outlook and Financial Guidance. Audentes Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference.

investors.autodesk.com investors.autodesk.com

Autodesk - Investor Relations - Investors

Autodesk 2D and 3D Design and Engineering Software. Q2 2016 Autodesk, Inc. Earnings Conference Call. 160;at 2:00 pm PT. Autodesk Second Quarter 2016 Earnings Call will be held on August 27, 2015 at 2:00pm Pacific Time. For the webcast, click here. Autodesk Investor Day 2015. September 29, 2015. Founded in 1982, Autodesk is headquartered in San Rafael, California. Investor Relations Program Specialist. Telephone: 415.507.6373. San Rafael, California 94903. 08/07/15 4:00 pm ET. Pricing delayed 20 minutes.

investors.autonation.com investors.autonation.com

AutoNation - Investor Relations - Investor Relations Home

Bringing the mid-size truck into the 21st century. AutoNation Announces Reported Retail New Vehicle Unit Sales of 29,875 in July 2015, Up 9% versus July 2014. AutoNation Reports Record Second Quarter EPS from Continuing Operations. AutoNation expects to announce August 2015 reported retail new vehicle unit sales on Wednesday, September 2, 2015. Energy and Autos Forum Town Hall Meeting. More Events and Presentations. Report of unscheduled material events or corporate event. AutoNation, Inc. (NYSE:AN).

investors.autosportsgroup.com.au investors.autosportsgroup.com.au

Error 404 Page Not Found

This page is currently unavailable. Sorry the page you were looking for appears to have been moved, deleted or does not exist. Please check the web address and try again.

investors.avagotech.com investors.avagotech.com

AVAGO - Company - Investor Center - Investor Center

My Avago Account :. My Avago Account :. Q3 2015 Avago Technologies Ltd Earnings Conference Call. 160;at 2:00 pm PT. Avago to Acquire Broadcom. The combination of Avago and Broadcom creates the world's leading diversified communications semiconductor company with combined annual revenues of approximately $15 billion. Avago to Acquire Broadcom Investor Presentation. With a heritage of innovation and a global presence, learn about the company's business model and end markets. Company Overview May 2015.

investors.avalanchebiotech.com investors.avalanchebiotech.com

Avalanche Biotechnologies | Investor Overview

Avalanche is a biopharmaceutical company committed to improving or preserving the sight of people with serious eye diseases with an unmet medical need. Using a next generation gene therapy platform, the Ocular BioFactory , the Company is developing product candidates designed to provide long-term efficacy by inducing a sustained expression of a therapeutic protein with the potential for a one-time administration in the eye. 160; 3.82. Data as of 08/14/15 4:00 pm ET. Minimum 15 minute delay. MENLO PARK, C...